chrisvoncsefalvay/vaers-outcomes huggingface dataset:
I can't use my arms at all; This spontaneous case was reported by a patient and describes the occurrence of VACCINATION SITE MOVEMENT IMPAIRMENT (I can't use my arms at all) in a  patient of an unknown age and gender who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) for COVID-19 prophylaxis.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (unknown route) 1 dosage form. On an unknown date, the patient experienced VACCINATION SITE MOVEMENT IMPAIRMENT (I can't use my arms at all). At the time of the report, VACCINATION SITE MOVEMENT IMPAIRMENT (I can't use my arms at all) outcome was unknown.        For mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Unknown), the reporter did not provide any causality assessments.   No relevant concomitant medications were reported. No treatment medication reported.
Strange sensation in my mouth/It still kind of feels numb, a little bit.; This is a Spontaneous case report received from a Pfizer Sponsored Program. A 30-years-old contactable consumer (patient) of an unspecified gender reported that to receive first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, formulation: Solution for injection, Lot Number: Unknown, and Expiration date: Unknown), via an unspecified route of administration on an unspecified date as 1st dose, single dose for COVID-19 immunization. The patient medical history and concomitant medications were not reported. It was reported that the patient took the Pfizer COVID vaccine number one shot and on an unspecified date experienced a strange sensation in mouth. She visits the dentist, and they give the shots to numb certain areas of the mouth when they go to work on the tooth or something like that. It felt just like that earlier. It still kind of feels numb, a little bit. But not as bad as 5 days earlier. The patient had this strange sensation. The events assessed as non-serious. The outcome of the event was unknown.
Received my first dose of Covid-19 Pfizer vaccine and after almost an hour of my injection shot, I started feeling stomach cramping. I then had menstrual spotting on the same day.  Before my vaccine I had already finished my monthly menstrual. On the next day my hands and feet started to sweat from time to time. Also, I will suddenly start to cry.
Seizure - 11-15-12. Headaches - ongoing since August 2012. Paresthesias of digits. Intermittent double vision.
pt recv vax & devel T104 maximum & inflamed rt axillary lymph nodes;approx the beginning of JUL pt lymph nodes had to be removed;cult of rt axillary lymph nodes revealed acid fact bacilli;sl swollen lymph & low temp;
Lump on inner left breast. Tender, swollen, painful. Developed 48 hours after dose.
Infant was crying, seem irritable, positive fever and had transient difficulties breathing, seen in emergency department and recovered without incident.
This spontaneous report as received from internet referred to three patients of unknown age. On an unknown date the patients were vaccinated with GARDASIL (Lot#, dose/frequency, route and duration were unspecified). Then on an unknown date the patients died (three deaths have been reported along with more reports of paralysis in girls who had gotten the poorly tested HPV vaccine). The date and cause of death were not reported. It was unknown whether autopsy was done. This is one of several reports that received from the same source. Additional information has been requested.
Patient reported migraine-like headache, photophobia, difficulty with speech and tingling of fingers in both hands which began 4d post vaccination.  Denied fever.  No previous migraine hx.
sick for six months; Initial information received on 20-Nov-2020 regarding an unsolicited valid non-serious case received from a Social media from consumer.   This case involves an adult patient who was sick for six months (illness), while the patient was received INFLUENZA VACCINE [INFLUENZA VACCINE].  Medical history, medical treatment, vaccination and family history were not provided.    On an unknown date, the patient received a dose of suspect INFLUENZA VACCINE produced by unknown manufacturer (lot number: not reported) via unknown route in unknown administration site for prophylactic vaccination.  On an unknown date, the patient was sick for six months (illness)  (latency unknown), administration of INFLUENZA VACCINE.  No laboratory data was provided.  Final diagnosis was illness.   Action taken was unknown for event.  It was not reported if the patient received a corrective treatment.  The outcome was reported as Unknown for illness.
sudden loss of consciousness, hypotension, fall resulting in concussion and frontal lobe bleed
unusual post vaccine discomfort that progressively worsened, a deep ache feeling Given Ultram , Keflex, Medrol dosepak, oxycodone, physical therapy
Seconds after administration, my son's eyes rolled back in his head and he became unresponsive, followed by seizure-like twitching.
Patient became pale and dizzy, gave him water. He then became unresponsive and started to shake slightly for a few seconds. He did not lose consciousness and began to respond again quickly.  Called EMS who responded and checked on patient. He did not go to hospital. Left after symptoms resolved in about 20 minutes.
Fever, lightheaded, severe muscle weakness and back pain. Headache. Increasing rash on back of scalp over 24 hours later.
Pfizer-BioNTech COVID-19 Vaccine EUA Arm soreness the evening of injection and the following day.  Headache the night of injection
Tdap given IM in (L) deltoid. Swelling and redness occurred at injection site 2 days later. Instructed to take PO BENADRYL and ice site. Mom stated that reaction improved within the same afternoon and was fine the next day.
got sick; This is a spontaneous report from a Pfizer-sponsored program. A contactable consumer (patient) reported that a male patient of an unspecified age received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number and expiration date not provided), via an unspecified route of administration on 29Dec2020 at single dose for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. Customer called and said that he got the first dose of covid-19 vaccine on 29Dec2020 and he got sick on an unspecified date, he tested negative twice on an unspecified date and wanted to know if he can get the second dose. The outcome of event was unknown.  Information about lot/batch number has been requested.
Nausea, Headache, body aches, cold sore started, diarrhea - started approx 1130 on 12/2/11 and all symptoms gone 12/3/11 at 0700.
Complained of being light headed, diaphoretic  Vital Signs: BP 108/72 HR 104 Resp 20 O2Sat 97 Skin Signs: Diaphoretic  Circulation: Cap refill <1sec  Respiratory: Breath sound clear bilaterally  Initial Treatment: Moved patient to triage, placed her in supine with feet elevated. Offered water and snacks. 3:04 PM Vital Signs: BP 108/61 HR 108 Resp 20 O2Sat 98 Skin Signs: Warm and dry  Circulation: Cap refill <1sec  Respiratory: Breath sound clear bilaterally  Vital Signs: BP 104/64 HR 90 Resp 18 O2Sat 98  Skin Signs: Warm and dry  Circulation: Cap refill <2sec  Respiratory: Breath sound clear bilaterally  Notes:  Patient stated she was feeling better after 10 min. Advised patient to seek medical attention if symptoms re-occur or worsen. Home with parent.
19JAN99 called in redness & pain @ site;20JAN99 came in to HU edema & warm to touch down to elbow;22JAn99 called out of hosp 2 days took ATB & used heating pad; FU states pt had significant swelling of the arm and erythema, both probably secondary to cellulitis and allergic reaction. Pt treated with antibiotics, Solu-Medrol and Vistaril in hospital. Sent home with Medrol dose pack, Vistaril, and Keflex.
The patient was diagnosed with Miller Fisher syndrome, a rare variant of Guillain Barre Syndrome.  The patient had ataxia and ophthalmoplegia.  The patient received 5 days of IV immune globulin 0.4 grams/kg daily for 4 days and then was discharged to a rehab facility.
Vaccinated patient at 9:12am. 1 minute later patient complained for feeling "funny and tingling". Took patient's blood pressure and dose with 50 mg of Diphenhydramine. Retook blood pressure and called 911. EMS requested patient go to the hospital to be checked out. Patient was conscious and left walking. She drove herself to the hospital.
This spontaneous report as received from a nurse refers to an unspecified number of patients of unknown demographics. No concurrent conditions or medical history were provided. On 29-AUG-2014, an unspecified number of patients had received improperly stored doses of GARDASIL injection (dose, frequency, route and lot # unknown). No symptoms reported. This is one of several reports from the same source. Additional information has been requested.
Shoulder was sore following the injection, which I wasn't worried by.  This morning I woke up feeling warm, my chest felt a little tight and  I have a headache.  My temperature  is within the "normal" range, but has stayed at least  1.5 degrees higher than it normally is, and I have been taking my temperature almost everyday, and sometimes 2-3 times.
Headache, Myalgia, Fever, NauseaVomiting, chills, pain at injection site Narrative:
Patient received first dose of shingrix on 8-8-22.  Patient reported that should not mover her arm starting right after injections, and it lasted until 8-9-22.  She experienced burning and rashes at the injection site, and broke out in bumpy rash which cause her to  go to emergency room on 8-10-22.  She reported it to the doctor, who recommended she receive the second dose, but patient is very reluctant.
Discovered redness and warmth at injection site in the morning at 8:30am the next day after shot. Put a cool compress on the arm for about 5 minutes and then put jojoba oil on the site. Repeated this every couple hours. It didn?t seem to help as child communicated that it was also hurting. His cheeks turned bright red at about 3:30pm. No fever.
Patient with an erythematous rash on right cheek and scalp minutes after administration of vaccines. No signs of anaphylaxis.  Follow up with mother the following day by phone - rash had resolved.
This case was reported by a healthcare professional, via a GSK representative, and described the occurrence of rash in a subject of unspecified age and gender who was vaccinated with HAVRIX (GlaxoSmithKline). On an unspecified date the subject received unspecified dose of HAVRIX (details unknown). Between 20 minutes and 18 hours after vaccination with HAVRIX, the subject experienced rash and hives. At the time of reporting the outcome of the events was unspecified. This case involves a pharmaceutical product complaint. The healthcare professional reported that there had been 3 incidents of rash and hives following vaccination with HAVRIX within the time frame of 20 minutes to 18 hours following the administration. This is case 2 of 3 (see case IDs A0878214A and A0878506A for the other reports). Follow-up received on 09 September 2010: QA analysis revealed the complaint to be unsubstantiated.
felt weird (lips numb); Taste of metal; Very tired; Lethargic; This spontaneous case was reported by a consumer and describes the occurrence of HYPOAESTHESIA ORAL (felt weird (lips numb)), DYSGEUSIA (Taste of metal), FATIGUE (Very tired) and LETHARGY (Lethargic) in a 70-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Concomitant products included PANTOPRAZOLE SODIUM SESQUIHYDRATE (PROTONEX) for an unknown indication.    On 18-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 18-Jan-2021, the patient experienced HYPOAESTHESIA ORAL (felt weird (lips numb)), DYSGEUSIA (Taste of metal), FATIGUE (Very tired) and LETHARGY (Lethargic). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency. On 19-Jan-2021, HYPOAESTHESIA ORAL (felt weird (lips numb)) and DYSGEUSIA (Taste of metal) had resolved. On 21-Jan-2021, FATIGUE (Very tired) and LETHARGY (Lethargic) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Most recent FOLLOW-UP information incorporated above includes: On 21-Jan-2021: Adverse events, treatment medication, concomitant medication updated.
A spontaneous report was from a physician, concerning a patient who received COVID-19 vaccine (mRNA-1273) and experienced local swelling 12 days after vaccination. The patient's medical history was not provided. No relevant concomitant medications were reported. On unknown date, the patient received their first of two planned doses of mRNA-1273 intramuscularly (lot number unknown) for prophylaxis of COVID-19 infection. On an unknown date, the physician called with question regarding vaccine reaction. Stated local swelling 12 days after vaccination. Treatment information not reported. Action taken with mRNA-1273 vaccine was unknown. The outcome of event, local swelling 12 days after vaccination, was unknown.; Reporter's Comments: Based on a temporal association and the established safety profile of mRNA-1273 vaccine, a causal association between the reported event and the product use cannot be excluded. Injection site swelling is consistent with the known safety profile of the vaccine
Body aches; Lethargy; Headache; Chills; Swollen lymph node on side shot was received; Diarrhea; Tender arm; This is a spontaneous report from a contactable consumer, the patient. A 34-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0171) via an unspecified route of administration in the left arm on 06May2021 at 16:30 (at the age of 34-years-old) as a single dose for COVID-19 immunisation. The patient did not have any medical history and known allergies. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. Concomitant medications included serialize and vitamin d nos (MANUFACTURER UNKNOWN); both taken for unknown indications from an unknown date and unknown if ongoing. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: EP7533) via an unspecified route of administration in the left arm on 15Apr2021 at 16:30 (at the age of 34-years-old) as a single dose for COVID-19 immunisation. On 07May2021, the patient had body aches, lethargy, headache, chills, swollen lymph node on side shot was received, diarrhea and tender arm. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events body aches, lethargy, headache, chills, swollen lymph node on side shot was received, diarrhea and tender arm was resolving at the time of this report.  No follow-up attempts are needed. No further information is expected.
Arm pain,  swelling,  red rash around injection site.  a bit queasy initially., tired.  Queasiness started Sunday - first full day of side effect.  lasted maybe 24 hours.   arm pain  worse first day or so,  slowly decreased.  rash  slowly went away - took at least a week.  swelling also slow to  go down..   only  minimal issue with itchiness.  used topical Avena  twice.
partial nasal duct obstruction on both sides; This spontaneous case was reported by a pharmacist and describes the occurrence of DACRYOSTENOSIS ACQUIRED (partial nasal duct obstruction on both sides) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced DACRYOSTENOSIS ACQUIRED (partial nasal duct obstruction on both sides). At the time of the report, DACRYOSTENOSIS ACQUIRED (partial nasal duct obstruction on both sides) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No relevant concomitant medications were reported.  Treatment for the event included systemic steroids.
Severe hair loss.  Approximately 60% volume of hair.  Especially on crown of head  down back of head.  Massive daily hair loss. started slowly in January and became severe amounts  by March.  Have enough loss that it is hard to conceal bald spots.
On 2/19/2020 area where Varivax was given parent noticed a red swollen knot.  Since then the knot has gotten smaller.  The provider diagnosed cellulitis of the left thigh on 2/21/2020.  the are felt warm.  Patient was a little fussy.  Provider treated the cellulitis with Keflex.. To be rechecked as necessary.
pt recv vax 21AUG96 redness noted 22AUG96 @5PM-no temp;c/o soreness-area inflamed size, baseball-feels firm;moist heat applied lt deltoid;
varicella - Information has been received from a licensed practical nurse concerning a 5 years old female who on 19 Sep 1997 was vaccinated with one dose of varicella virus vaccine live.  On 02 Apr 2000 the patient expericenced varicella.  The patient's father statated this was the mildest case he had seen in his children
A report was received from a health care professional on 10/04/2002, concerning a 29 year old female vaccinee who inadvertently received an overdose Fluvirin on 04/10/2002. On 04/10/2002 the vaccinee inadvertently received 5ml of Fluvirin. The vaccinee has received influenza vaccination (brand unspecified) for the 2000-2001 and 2001-2002 formulations without any adverse effects. At the time of reporting the vaccinee did not experience any effects from the event. There was insufficient information to determine the reporters causality assessment. Update1. 11/14/2002: The vaccinee experienced pain, throbbing, heat and swelling on the 10/04/2002. The events resolved on 10/04/2002. The reporter has assessed the relationship of the vaccine to the events as probable.
11/7/11 received varicella immunization at 9:00 AM - 11/8/11 at 800 AM the injection site was 1/2 cm red, slightly warm to touch, no fever. Ice pack given. 11/9/11 8:15AM. 3 1/2 inch (9cm) warm/tender to touch erythematous area at site of injection was seen by NP, ice pack & 200mg ibuprofen given. Return to clinic if worsens, or in AM for recheck.
positive COVID-19 test within the period of waiting for the second dose; positive COVID-19 test within the period of waiting for the second dose; This is a spontaneous report from a contactable pharmacist. A female patient of an unspecified age received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE), via an unspecified route of administration, on an unspecified date as a single dose for COVID-19 immunisation. The patient's medical history was not reported. The patient had no concomitant medications. The patient experienced positive COVID-19 test within the period of waiting for the second dose on an unspecified date. The pharmacist was questioning if they should keep the scheduled date for the second dose or change it. The patient underwent lab tests and procedures which included COVID-19 test: positive on an unspecified date. The clinical outcome of positive COVID-19 test within the period of waiting for the second dose was unknown.  The batch/lot number for the vaccine, BNT162B2, was not provided and will be requested during follow up.; Sender's Comments: The efficacy of a drug varies from patient to patient and can be affected by different factors; however, a contributory role of the suspect product BNT162B2 or comirnaty to the reported event Drug ineffective and covid-19 cannot be ruled out.
I got a knot and soreness in my arm directly below the injection site that began immediately after the shot and lasted for one day.  24 hours after the vaccine, I began a low grade fever and general fatigue that lasted for several hours.  The next morning, I felt fine.
Irritable bowel syndrome symptoms; Symptoms of post-traumatic stress disorder; Fever; pain at injection site with pain and soreness; Fatigue; Headache; This spontaneous case was reported by a consumer and describes the occurrence of IRRITABLE BOWEL SYNDROME (Irritable bowel syndrome symptoms), POST-TRAUMATIC STRESS DISORDER (Symptoms of post-traumatic stress disorder), PYREXIA (Fever), VACCINATION SITE PAIN (pain at injection site with pain and soreness) and FATIGUE (Fatigue) in an adult female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.    Co-suspect product included non-company product ADALIMUMAB (HUMIRA) solution for injection for Crohn's disease.    Concurrent medical conditions included Crohn's disease.   On 06-Jan-2020, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 01-Feb-2020, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form and ADALIMUMAB (HUMIRA) (Subcutaneous) Citrate Free. On an unknown date, the patient experienced IRRITABLE BOWEL SYNDROME (Irritable bowel syndrome symptoms), POST-TRAUMATIC STRESS DISORDER (Symptoms of post-traumatic stress disorder), PYREXIA (Fever), VACCINATION SITE PAIN (pain at injection site with pain and soreness), FATIGUE (Fatigue) and HEADACHE (Headache). At the time of the report, IRRITABLE BOWEL SYNDROME (Irritable bowel syndrome symptoms) and POST-TRAUMATIC STRESS DISORDER (Symptoms of post-traumatic stress disorder) had not resolved and PYREXIA (Fever), VACCINATION SITE PAIN (pain at injection site with pain and soreness), FATIGUE (Fatigue) and HEADACHE (Headache) had resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): In 2020, Body temperature: 101.1 for 48 hrs after covid booster.         It was unknown if patient was enrolled in a COVID-19 Vaccine Trial.  No concomitant and treatment medication were provided.  The reporter's causality for the events of irritable bowel syndrome, fever, vaccination site pain, fatigue and headache with Humira(adalimumab) was no reasonable possibility and for post traumatic stress disorder causality was not provided.  This case was identified as part of a retrospective clean-up activity where certain emails received in the Moderna mailbox were missed to be booked-in
ACHENESS; TIREDNESS; This spontaneous report received from a patient. The patient's height, and weight were not reported. The patient's pre-existing medical conditions included the patient had no known allergies. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, intramuscular, batch number: 1805031, expiry: UNKNOWN) dose was not reported, administered on 12-MAR-2021 in left arm for prophylactic vaccination. No concomitant medications were reported. On 12-MAR-2021, the patient experienced acheness. On 12-MAR-2021, the patient experienced tiredness. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from acheness, and tiredness on 2021. This report was non-serious.
mistakenly drew up Moderna COVID19 vaccine at 1.0 ml instead of the prescribed dosage of 0.5ml  and injected in right deltoid.
pt recvd vax;lt arm sore 5mar; c/o spasms lt arm; lasting 3-4 mins;shooting pains to fingers for several days;13mar no more problems;